Who owns FOGHORN THERAPEUTICS INC?
- Ticker: FHTX
- CUSIP Number: 344174107
Tip: Access positions for across all investors
Analyze quarterly positions in Foghorn Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Foghorn Therapeutics stock
Who bought or sold FOGHORN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Flagship Ventures Management | 13M | $82M | 0% | Dec 2023 |
|
| Raymond James & Associates | 2.1M | $13M | 45% | Dec 2023 |
|
| Euclidean Capital | 1.6M | $10M | 0% | Dec 2023 |
|
| Vanguard Group | 1.0M | $6.6M | 1% | Dec 2023 |
|
| Artal Group | 721k | $4.6M | -58% | Dec 2023 |
|
| Point72 Asset Management | 540k | $3.5M | 90% | Dec 2023 |
|
| Alphabet | 501k | $3.2M | 0% | Dec 2023 |
|
| Rockwood Wealth Management | 215k | $1.4M | 0% | Dec 2023 |
|
| Jacobs Levy Equity Management | 108k | $694k | 120% | Dec 2023 |
|
| PanAgora Asset Management | 97k | $626k | 181% | Dec 2023 |
|
| Bank of New York Mellon | 57k | $369k | -19% | Dec 2023 |
|
| Charles Schwab Investment Management | 55k | $358k | 0% | Dec 2023 |
|
| Exchange Traded Concepts | 47k | $316k | 119% | Mar 2024 |
|
| Baker Bros. Advisors | 45k | $290k | 0% | Dec 2023 |
|
| GSA Capital Partners | 41k | $266k | 100% | Dec 2023 |
|
| Barclays | 33k | $212k | 823% | Dec 2023 |
|
| Alta Wealth Advisors | 30k | $194k | 100% | Dec 2023 |
|
| Bank of America Corporation | 29k | $188k | 112% | Dec 2023 |
|
| Rhumbline Advisers | 26k | $167k | -2% | Dec 2023 |
|
| CornerCap Investment Counsel | 26k | $167k | 0% | Dec 2023 |
|
| UBS Group | 23k | $151k | 124% | Dec 2023 |
|
| Goldman Sachs Group | 14k | $92k | -11% | Dec 2023 |
|
| Hsbc Holdings | 14k | $91k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 13k | $85k | -37% | Dec 2023 |
|
| Jane Street | 13k | $83k | 100% | Dec 2023 |
|
| Fiduciary Trust Company | 11k | $70k | 0% | Dec 2023 |
|
| American International | 10k | $65k | 0% | Dec 2023 |
|
| Alliancebernstein | 10k | $65k | -7% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 10k | $64k | 0% | Dec 2023 |
|
| Lazard Asset Management | 9.0k | $57k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 6.5k | $42k | 5% | Dec 2023 |
|
| Wells Fargo & Company | 5.3k | $34k | 30% | Dec 2023 |
|
| NISA Investment Advisors | 5.0k | $32k | 788% | Dec 2023 |
|
| Citigroup | 2.9k | $19k | 438% | Dec 2023 |
|
| Amalgamated Bank | 2.9k | $19k | -7% | Dec 2023 |
|
| Legal & General Group | 2.0k | $13k | 0% | Dec 2023 |
|
| New York State Common Retirement Fund | 1.9k | $12k | -2% | Dec 2023 |
|
| Summit Investment Advisors | 1.5k | $9.9k | 0% | Dec 2023 |
|
| Sunbelt Securities | 1.5k | $10k | 0% | Mar 2024 |
|
| Washington Trust Company | 1.5k | $9.7k | 0% | Dec 2023 |
|
| Capital Analysts | 547.00 | $4.0k | 0% | Dec 2023 |
|
| VisionPoint Advisory Group | 210.00 | $1.4k | 0% | Dec 2023 |
|
| TFC Financial Management | 123.00 | $794.001900 | 0% | Dec 2023 |
|
| Russell Investments | 100.00 | $645.000000 | 100% | Dec 2023 |
|
| Capital Advisors | 7.00 | $0 | 100% | Mar 2024 |
|
| Zurcher Kantonalbank | 2.00 | $13.000000 | -100% | Dec 2023 |
|
| CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Foghorn Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Deerfield Management Company | Sep 2023 | 778k | $3.9M |
| GW & Wade | Sep 2023 | 108k | $539k |
| Ikarian Capital | Sep 2023 | 15k | $77k |
| MetLife Investment Advisors | Sep 2023 | 11k | $57k |
| Metropolitan Life Insurance Company | Sep 2023 | 1.3k | $6.5k |
| China Universal Asset Management | Sep 2023 | 1.1k | $5.0k |
| Advisor Group Holdings | Sep 2023 | 300.00 | $1.5k |
| Daiwa Securities Group | Sep 2023 | 168.00 | $1.0k |